Matthew Joshua Frank MD

Clinical Fellow in Medicine, Beth Israel Deaconess Medical Center

300 Pasteur DrStanford, CA 94305
Phone+1 650-723-4000

Dr. Frank is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Frank's full profile Already have an account?

Education & Training

Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematology and Medical Oncology, 2015 - 2018
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2011 - 2014
David Geffen School of Medicine at UCLAClass of 2011

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

CA State Medical License 2013 - 2028
MA State Medical License Active through 2013
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Clonal hematopoiesis and cytopenias following CAR19 therapy.
Mark P Hamilton, Nick Phillips, Troy Noordenbos, Jan Boegeholz, Takeshi Sugio
Nature Genetics. 2026-11-02
Post CAR-T Measurable Residual Disease Monitoring in Mantle Cell Lymphoma Enables Early Detection of Disease Relapse.
Snegha Ananth, Neha Agarwal, Bita Sahaf, Allison Jacob, Lik Wee Lee
American Journal of Hematology. 2026-08-01
2 citations
Superior Chronic Graft-versus-Host Disease-Free Survival with Post-Transplant Cyclophosphamide Relative to Tacrolimus/Methotrexate in Myeloablative HLA-Matched Allogen...
Alfonso Molina, Quenton Rashawn Bubb, Hrishikesh K Srinagesh, Ryan Yee, Sally Arai
Transplantation and Cellular Therapy. 2026-07-01

Abstracts/Posters

Identification of Two CAR T-Cell Populations Associated with Complete Response or Progressive Disease in Adult Lymphoma Patients Treated with Axi-Cel
Matthew J. Frank, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Phase I Trial Using CD19/CD22 Bispecific CAR T Cells in Pediatric and Adult Acute Lymphoblastic Leukemia (ALL)
Matthew J. Frank, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
A Phase I/II Trial of Intratumoral CpG, Local Low-Dose Radiation, and Oral Ibrutinib in Patients with Low-Grade B-Cell Lymphoma
Matthew J. Frank, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

Monitoring ctDNA in r/r DLBCL patients following the CAR T-cell therapy axicabtagene ciloleucel: Day 28 landmark analysis.
ASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019
Intratumoral Injection of CpG-ODN Plus Systemic Ibrutinib Induces an Anti-Tumor Immune Response Affecting T Cell Subsets in the Microenvironment of Both Injected and N...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018